Skip to main content
. 2015 Nov 15;8(11):21981–21990.

Table 5.

Global tumor heterogeneity in the context of molecular subtypes

Molecular subtype Number of samples classified as globally heterogenous (%)
ER+/PR+/HER2+ 12/117 (10.3%)
ER+/PR+/HER2- 11/193 (5.7%)
ER-/PR-/HER2+ 9/17 (52.9%)
ER-/PR-/HER2- 7/26 (27.0%)
P value (chi square) <0.000001